Weekly Stock Recommendation [25-10-2021 to 29-10-2021]
Script Name Call No Buy/Sell CMP Buy upto 1st Target 2nd Target Stop Loss High/Low Remark
SBIN W-1 Buy 502.95 498 508 513++ 494 513.50 2nd Target Hit
ICICIBANK W-2 Buy 759.30 752 768 775++ 745 867 2nd Target Hit
RELIANCE W-3 Buy 2627.40 2610 2690 2720++ 2600 2680 -
AXISBANK W-4 Buy 816.70 805 828 832++ 800 855 2nd Target Hit
JUBLFOOD W-5 Buy 3701.25 3650 3789 3820++ 3630 - 2nd Target Hit
LT W-6 Buy 1792.25 1780 1828 1840++ 1765 - -
SBICARD W-7 Buy 1129.50 1115 1145 1160++ 1100 1148 1st Target Hit
TVSMOTOR W-8 Buy 619.80 604 630 639++ 598 - only Risk Trader
Main-line IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Adani Wilmar Limited IPO Details - - ₹ - Cr ₹ - - ₹ - -
Skanray Technologies IPO Details - - ₹ - Cr ₹ - - ₹ - -
Mobikwik IPO Details - - ₹ - Cr ₹ - - ₹ - -
Paytm IPO Details - - ₹ - Cr ₹ - - ₹ - -
Paytm IPO Details 08-11-2021 10-11-2021 ₹ - Cr ₹ - - ₹ - -
Policy Bazaar IPO Details 01-11-2021 03-11-2021 ₹ 6017.50 Cr ₹ 980 15 ₹ 14,700 -
S.J.S. Enterprises Limited IPO Details 01-11-2021 03-11-2021 ₹ 800 Cr ₹ 542 27 ₹ 14,634 -
Sigachi Industries Limited IPO Details 01-11-2021 03-11-2021 ₹ 125.43 Cr ₹ 163 90 ₹ 14,670 -
Fino Payments Bank Limited IPO Details 29-10-2021 02-11-2021 ₹ 1200.29 Cr ₹ 577 25 ₹ 14,425 -
Nykaa IPO Details 28-10-2021 01-11-2021 ₹ 5351.92 Cr ₹ 1125 12 ₹ 13,500 -
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Nidan Laboratories and Healthcare IPO Details 28-10-2021 02-11-2021 ₹ 50 Cr ₹ 125 1000 ₹ 1,25,000 -
Kotyark Industries IPO Details 21-10-2021 25-10-2021 ₹ 11.26 Cr ₹ 51 2000 ₹ 1,02,000 -

Aarti Drugs Limited Buy-Back Details

Part of the USD 500 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984.Since its inception, the Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.

Over the years, the Company has been able to carve a niche for itself and is looking forward to expand the volumes. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market.
Aarti Drugs Limited Buy-Back Details
Date of Board Meeting for Buyback Proposal 15-03-2019
Date of Buyback Approval 15-03-2019
Date Public Announcement of Buyback 15-03-2019
Buyback Type Tender Offer
Buyback Record Date 29-03-2019
Buyback Opening Date -
Buyback Closing Date -
Buyback Amount ₹ 25.389 Cr
Buyback Number of Share 2,82,100
Buyback Price ₹ 900 Per Share
Face Value ₹ 10
Holding Time 3 Months
- -
Profit acceptance Ratio
Buy 222 Shares at CMP ₹ 653 [2,00,000/900= 222]
Acceptance Ratio 33% 50% 75% 100%
Buy Price ₹ 653 ₹ 653 ₹ 653 ₹ 653
Amount Invested in Buyback ₹ 1,44,966 ₹ 1,44,966 ₹ 1,44,966 ₹ 1,44,966
No. of Shares Buy 222 222 222 222
Earning Per Share ₹ 247 ₹ 247 ₹ 247 ₹ 247
No. of Shares Buy-Back 73 111 167 222
BuyBack Profit ₹ 18095 ₹ 27417 ₹ 41125 ₹ 54834
Profit(%) - % - % - % - %
Aarti Drugs Limited Contact Details
AARTI DRUGS LIMITED, 
Mahendra Industrial Estate, Ground Floor,
Road No 29, Plot No 109-D, 
SION (East), MUMBAI- 400 022.( INDIA)
TEL: ++91 22 2401 9025 (30 LINES)
FAX: ++91 22 2407 3462 / ++91 22 2407 0144
Email ID:- investorrelations@aartidrugs.com
Website :- http://www.aartidrugs.co.in
Registrar of Aarti Drugs Limited
-

0 Response to "Aarti Drugs Limited Buy-Back Details"

Post a Comment